Latest Regulatory News

Cygnus Metals has clarified that its recent share price and volume spike stemmed from new assay results at its Golden Eye prospect and broader copper sector dynamics, confirming compliance with ASX disclosure rules.

Syntara Limited’s lead drug candidate SNT-5505 has secured FDA Fast Track designation, expediting its development for treating myelofibrosis, a rare and serious blood cancer with limited therapies.

Hutchison Telecommunications (Australia) Limited (HTAL) has recommended shareholders accept an off-market takeover bid by majority owner HTABV, offering a significant premium over recent trading prices. Independent experts affirm the offer as fair and reasonable, setting the stage for a potential full acquisition.

Opyl Limited unveils a bold strategic pivot to enhance its AI-driven drug discovery platform, leveraging a vast proprietary dataset and leadership upgrades to redefine clinical trial innovation.

Argenica Therapeutics faces a clinical hold from the US FDA on its stroke drug trial application, though its Australian Phase 2 study remains unaffected and on track.

Cazaly Resources has secured key approvals to commence drilling at the Duke of York prospect within its Goongarrie Gold Project, aiming to validate promising historical gold intercepts and explore new mineralisation along a prolific gold corridor in Western Australia.

Optiscan Imaging Ltd has launched InSpecta™, a cutting-edge microscopic imaging device tailored for veterinary medicine, marking its strategic entry into a booming $12 billion US market. The device promises to revolutionize diagnostics and treatment for companion animals with real-time, non-invasive imaging.

Firebrick Pharma has published its pivotal Phase 3 trial results for Nasodine nasal spray, confirming its effectiveness and safety in treating the common cold, especially when used early.

Prodigy Gold NL has announced a non-renounceable entitlement offer aiming to raise approximately $6.35 million to fund exploration and development across its key gold projects in the Tanami region. The offer is partially underwritten, providing a degree of funding certainty amid ongoing market and operational risks.

Imricor Medical Systems has secured CE Mark approval for its NorthStar Mapping System ahead of schedule, marking a pivotal shift to software-centric MRI-guided cardiac interventions across Europe and the Middle East.

Vection Technologies has launched its Algho AI Sign Language solution on Amazon Web Services Marketplace, targeting enhanced accessibility across Europe. Early contracts signal strong market interest in AI-driven communication tools for the Deaf and hard-of-hearing community.

Solis Minerals is set to delist from the TSX Venture Exchange, consolidating its primary listing on the ASX and planning a re-domiciliation to Australia to sharpen its focus on copper-gold exploration in Peru.